Evogene Ltd
EVGN1.190USD
+0.040+3.48%
Close 11/10, 16:00（ET）Quotes delayed by 15 min
10.37MMarket Cap
LossP/E TTM
More Details of Evogene Ltd Company
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Evogene Ltd Info
Ticker SymbolEVGN
Company nameEvogene Ltd
IPO dateJun 11, 2007
CEODr. Arnon Heyman
Number of employees117
Security typeOrdinary Share
Fiscal year-endJun 11
Address13 Gad Feinstein Street
CityREHOVOT
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code7638517
Phone97289311900
Websitehttps://evogene.com/
Ticker SymbolEVGN
IPO dateJun 11, 2007
CEODr. Arnon Heyman
Company Executives of Evogene Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Kenny Green
Kenny Green
Investor Relations
Investor Relations
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dan Michael Falk
Mr. Dan Michael Falk
Independent Director
Independent Director
--
--
Dr. Brian Ember
Dr. Brian Ember
Chief Executive Officer of AgPlenus Limited
Chief Executive Officer of AgPlenus Limited
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Recanati (Leon Yehuda)
0.96%
Virtu Americas LLC
0.37%
Citadel Advisors LLC
0.25%
Two Sigma Investments, LP
0.24%
Morgan Stanley & Co. LLC
0.17%
Other
98.01%
Shareholders
Shareholders
Proportion
Recanati (Leon Yehuda)
0.96%
Virtu Americas LLC
0.37%
Citadel Advisors LLC
0.25%
Two Sigma Investments, LP
0.24%
Morgan Stanley & Co. LLC
0.17%
Other
98.01%
Shareholder Types
Shareholders
Proportion
Individual Investor
0.96%
Research Firm
0.92%
Hedge Fund
0.49%
Investment Advisor
0.20%
Investment Advisor/Hedge Fund
0.05%
Other
97.38%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
53
144.62K
1.66%
-721.10K
2025Q2
54
520.27K
5.97%
-411.44K
2025Q1
55
520.29K
6.01%
-409.22K
2024Q4
56
495.82K
9.24%
-272.31K
2024Q3
56
646.41K
12.68%
+45.84K
2024Q2
57
498.30K
80.86%
-140.56K
2024Q1
62
510.64K
10.05%
-122.17K
2023Q4
69
544.86K
11.19%
-474.65K
2023Q3
76
590.60K
14.30%
-53.35K
2023Q2
75
185.66K
4.46%
-461.57K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Recanati (Leon Yehuda)
83.89K
0.96%
--
--
Mar 17, 2025
Virtu Americas LLC
32.02K
0.37%
+32.02K
--
Jun 30, 2025
Citadel Advisors LLC
21.37K
0.25%
+21.37K
--
Jun 30, 2025
Two Sigma Investments, LP
21.09K
0.24%
+7.53K
+55.50%
Jun 30, 2025
Morgan Stanley & Co. LLC
15.16K
0.17%
+600.00
+4.12%
Jun 30, 2025
Jane Street Capital, L.L.C.
15.02K
0.17%
-18.71K
-55.46%
Jun 30, 2025
BNP Paribas Securities Corp. North America
14.12K
0.16%
+1.30K
+10.14%
Jun 30, 2025
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.11%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
6.73K
0.08%
-12.02K
-64.10%
Jun 30, 2025
Geode Capital Management, L.L.C.
4.20K
0.05%
--
--
Aug 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Date
Type
Ratio
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
